Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Sang Geon Kim"

Article category

Keywords

Publication year

"Sang Geon Kim"

Review

Artificial intelligence, epidemiology, methodology, or others

Roles of X-box binding protein 1 in liver pathogenesis
Jihoon Tak, Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol 2025;31(1):1-31.
Published online October 2, 2024
DOI: https://doi.org/10.3350/cmh.2024.0441
The prevalence of drug-induced liver injury (DILI) and viral liver infections presents significant challenges in modern healthcare and contributes to considerable morbidity and mortality worldwide. Concurrently, metabolic dysfunctionassociated steatotic liver disease (MASLD) has emerged as a major public health concern, reflecting the increasing rates of obesity and leading to more severe complications such as fibrosis and hepatocellular carcinoma. X-box binding protein 1 (XBP1) is a distinct transcription factor with a basic-region leucine zipper structure, whose activity is regulated by alternative splicing in response to disruptions in endoplasmic reticulum (ER) homeostasis and the unfolded protein response (UPR) activation. XBP1 interacts with a key signaling component of the highly conserved UPR and is critical in determining cell fate when responding to ER stress in liver diseases. This review aims to elucidate the emerging roles and molecular mechanisms of XBP1 in liver pathogenesis, focusing on its involvement in DILI, viral liver infections, MASLD, fibrosis/cirrhosis, and liver cancer. Understanding the multifaceted functions of XBP1 in these liver diseases offers insights into potential therapeutic strategies to restore ER homeostasis and mitigate liver damage.

Citations

Citations to this article as recorded by  Crossref logo
  • Early oxidative protein modifications and gut damage/leakiness contribute to drug-induced acute liver failure
    Wiramon Rungratanawanich, Ying Qu, Andrew Holmes, Neil Kaplowitz, Byoung-Joon Song
    Clinical and Molecular Hepatology.2026; 32(1): e29.     CrossRef
  • HOCl and viscosity dual-responsive fluorescent probe for accurate discrimination between early hepatocellular carcinoma and acute liver injury
    Jiakang Sun, Lidong Cao, Mengmeng Dong, Yumeng Liu, Yun Wang, Yong Zhan
    Materials Today Bio.2026; 37: 102816.     CrossRef
  • Association between estimated glucose disposal rate and the risk of MAFLD in American adults: a cross-sectional study
    Yuhang Zhou, Bang Wang, Miaoxin Wu, Han Hong, Gaochao Li, Minhui Xu
    Scientific Reports.2025;[Epub]     CrossRef
  • The Cardiohepatic Axis in Metabolic Disease
    Andrew Hakeem, Jop van Berlo, Xavier S. Revelo
    JACC: Basic to Translational Science.2025; 10(7): 101309.     CrossRef
  • Beyond ER Stress: The Pleiotropic Roles of XBP1 in Development and Regeneration
    Delan Huang, Fan Gu, Jingzhi Ma, Zhi Chen
    Biomedicines.2025; 13(11): 2663.     CrossRef
  • Association between estimated glucose disposal rate and metabolic-associated fatty liver disease among US adults: A cross-sectional study
    Rong He, Kecen Zhao
    Medicine.2025; 104(44): e45652.     CrossRef
  • Inositol-requiring enzyme 1 alpha is essential for dentinogenesis
    Qian Xu, Tian Liang, Jiahe Li, Suzhen Wang, Hua Zhang, Julie Hollien, Takao Iwawaki, Chunlin Qin, Yongbo Lu
    Frontiers in Physiology.2025;[Epub]     CrossRef
  • 10,628 View
  • 230 Download
  • 7 Web of Science
  • Crossref
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Alcohol-related liver disease

Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol 2020;26(4):715-727.
Published online September 22, 2020
DOI: https://doi.org/10.3350/cmh.2020.0173
Alcoholic and non-alcoholic liver diseases begin from an imbalance in lipid metabolism in hepatocytes as the earliest response. Both liver diseases share common disease features and stages (i.e., steatosis, hepatitis, cirrhosis, and hepatocellular carcinoma). However, the two diseases have differential pathogenesis and clinical symptoms. Studies have elucidated the molecular basis underlying similarities and differences in the pathogenesis of the diseases; the factors contributing to the progression of liver diseases include depletion of sulfhydryl pools, enhanced levels of reactive oxygen and nitrogen intermediates, increased sensitivity of hepatocytes to toxic cytokines, mitochondrial dysfunction, and insulin resistance. Endoplasmic reticulum (ER) stress, which is caused by the accumulation of misfolded proteins and calcium depletion, contributes to the pathogenesis, often causing catastrophic cell death. Several studies have demonstrated a mechanism by which ER stress triggers liver disease progression. Autophagy is an evolutionarily conserved process that regulates organelle turnover and cellular energy balance through decomposing damaged organelles including mitochondria, misfolded proteins, and lipid droplets. Autophagy dysregulation also exacerbates liver diseases. Thus, autophagy-related molecules can be potential therapeutic targets for liver diseases. Since ER stress and autophagy are closely linked to each other, an understanding of the molecules, gene clusters, and networks engaged in these processes would be of help to find new remedies for alcoholic and non-alcoholic liver diseases. In this review, we summarize the recent findings and perspectives in the context of the molecular pathogenesis of the liver diseases.

Citations

Citations to this article as recorded by  Crossref logo
  • Targeting CD44-Hyaluronic Acid Signalling in Obesity Treatment: Insights from Small Molecules and Nanobioconjugates
    Daniel Ejim Uti, Wilson Achu Omang, Esther Ugo Alum, Okechukwu Paul-Chima Ugwu, Margaret Amieibi Wokoma, Rowland Inalegwu Oplekwu, Item Justin Atangwho, Godwin Eneji Egbung
    Nutrition and Metabolic Insights.2026;[Epub]     CrossRef
  • The Role of Crosstalk Between the Unfolded Protein Response and Autophagy in Diseases Associated with Sympathetic Nervous System Imbalance: Mechanisms and Therapeutic Perspectives
    Bo Xu, Yi Yang, Renjun Wang
    International Journal of Molecular Sciences.2026; 27(3): 1282.     CrossRef
  • Bletilla striata polysaccharides alleviate metabolic dysfunction-associated steatotic liver disease through enhancing hepatocyte RelA/ HNF1α signaling
    Yi-Huai He, Li-Li Ou, Jin-Lian Jiang, Yun-Fen Chen, Aikedaimu Abudukeremu, Yuan Xue, Mao-Yuan Mu, Wei-Wei Zhong, De-Lin Xu, Xuan-Yu Meng, Ya-Qun Guan
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Endoplasmic reticulum stress in liver fibrosis: Mechanisms and therapeutic potential
    Tiantian Wang, Guoqing Xia, Xue Li, Mingxu Gong, Xiongwen Lv
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167695.     CrossRef
  • Immune Checkpoints and the Immunology of Liver Fibrosis
    Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
    Livers.2025; 5(1): 5.     CrossRef
  • FAM134B-mediated ER-phagy alleviates alcohol-related liver fibrosis by reducing endoplasmic reticulum stress
    Tiantian Wang, Xue Li, Guoqing Xia, Mingxu Gong, Xiongwen Lv
    International Journal of Biological Macromolecules.2025; 308: 142395.     CrossRef
  • Endoplasmic reticulum stress in gut inflammation: Implications for ulcerative colitis and Crohn’s disease
    Ting Zheng, Kai-Yue Huang, Xu-Dong Tang, Feng-Yun Wang, Lin Lv
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
    Young-Min Jee, Jeong-Yoon Lee, Tom Ryu
    Biomedicines.2025; 13(5): 1260.     CrossRef
  • Changing complexity into simplicity: visualization of endoplasmic reticulum autophagy employing a self-deliver viscosity sensor by lifetime imaging
    Nan Sheng, Jie Niu, Xingyu Lyu, Yangang Su, Qing Lyu, Wendong Jin, Miao Cheng, Jiaxuan Wang, Li Li, Xiaoqiang Yu
    Biosensors and Bioelectronics.2025; 286: 117596.     CrossRef
  • Targeting endoplasmic reticulum proteostasis in liver fibrosis: From signaling mechanisms to therapeutic opportunities
    Yawei Kong, Zhengyang Chen, Zhentian Nie, Wei Chen
    Pharmacological Research.2025; 217: 107823.     CrossRef
  • Morin: a promising hepatoprotective agent against drug and chemical-induced liver injury
    Anandakumar Pandi, Nabendu Sen, Vanitha Manickam Kalappan, Vanita Lal
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(12): 16385.     CrossRef
  • LAPTM4B as a key regulator in the copper-induced endoplasmic reticulum–lysosome interplay disorder in duck liver and the protective role of baicalin
    Hongyu Shang, Xueyan Dai, Jing Chen, Chenghong Xing, Xiaona Gao, Huabin Cao, Guoliang Hu, Haotang Li, Mingwen Hu, Fan Yang
    Journal of Animal Science and Biotechnology.2025;[Epub]     CrossRef
  • Chaize mixture alleviates NAFLD by regulating Glipr2-related autophagy/NLRP3 signaling
    Xiaohui Zhang, Juan Shi, Yutong Liu, Yun Lu, Jing Ji, Xueqian Wang, Jinying Liu, Fafeng Cheng, Qiuxia Zhang, Chongyang Ma
    International Immunopharmacology.2025; 166: 115600.     CrossRef
  • AMPK affects the development of early-stage NAFLD by activating autophagy and fatty acid oxidation
    Mei-yu Jin, Hao Yu, Qiong Deng, Zhu Wang, Hui Liang
    Scientific Reports.2025;[Epub]     CrossRef
  • Characterization of aggrephagy-related genes to predict the progression of liver fibrosis from multi-omics profiles
    Jing Chen, Zi-Cheng Zhou, Yang Yan, Shu-Zhen Wu, Tao Ma, Han Xuan, Ruo-Chun Wang, Chi-Yu Gu, Yi-Heng Liu, Qing-Qing Liu, Si-Jia Ge, Wei Huang, Cui-Hua Lu
    Biomedical Technology.2024; 5: 46.     CrossRef
  • Upregulation of FAM134B inhibits endoplasmic reticulum stress‐related degradation protein expression and promotes hepatocellular carcinogenesis
    Houhong Wang, Lu Liu, Huihui Gong, Heng Li
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
    Qiannan Ren, Qiming Sun, Junfen Fu
    Autophagy.2024; 20(2): 221.     CrossRef
  • Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1α-XBP1 pathway
    Yue An, Changyong Xu, Wenmin Liu, Ji Jiang, Pengfei Ye, Mei Yang, Weihua Zhu, Jingjing Yu, Manman Yu, Wuyi Sun, Jian Hong, Huan Qiu, Wei Wei, Shihao Zhang
    Cellular Signalling.2024; 113: 110935.     CrossRef
  • TMT-based quantitative proteomics analysis of Sprague-Dawley rats liver reveals Triphenyltin induced liver damage and lipid metabolism disorders
    Xijuan Ren, Penghui Mao, Zhi Li, Mingqing Qian, Xinxin Deng, Hui Liu, Li Wang
    Pesticide Biochemistry and Physiology.2024; 198: 105739.     CrossRef
  • Advances in Research on the Role of Systemic Inflammatory in Mediating Acute-on-Chronic Liver Failure
    婷婷 卞
    Advances in Clinical Medicine.2024; 14(04): 1447.     CrossRef
  • New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome
    Jinyue Zhao, Liyun Duan, Jiarui Li, Chensi Yao, Guoqiang Wang, Jia Mi, Yongjiang Yu, Lu Ding, Yunyun Zhao, Guanchi Yan, Jing Li, Zhixuan Zhao, Xiuge Wang, Min Li
    Biomedicine & Pharmacotherapy.2024; 176: 116807.     CrossRef
  • Ultrastructural and immunohistochemical evaluation of hyperplastic soft tissues surrounding dental implants in fibular jaws
    Kezia Rachellea Mustakim, Mi Young Eo, Mi Hyun Seo, Hyeong-Cheol Yang, Min-Keun Kim, Hoon Myoung, Soung Min Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Mechanistic Insight into the Autophagic and Apoptotic Activity of Kaempferol on Liver Cancer Cells
    Nidhi Sharma, Meenakshi Gupta, Pragya Anand, Yusuf Akhter, Noura Al-Dayan, Hind Majed, Subhrajit Biswas, Sher Ali, Maryam Sarwat
    OncoTargets and Therapy.2024; Volume 17: 579.     CrossRef
  • Perfluorooctane sulfonate causes damage to L-02 cells via Wnt/β-catenin signal path and endoplasmic reticulum stress pathway
    Cui Jiajing, Yan Shuqi, Ma Haoyan, Wang Pingwei, Liu Dongge, Liu Yanping, Chen Qianqian, Fajrin Saleh, Ren Shuping
    Toxicology and Industrial Health.2024; 40(12): 653.     CrossRef
  • Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?
    Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, Abhishek Kumar, Jaya Bansal, Ata Fateh, Deepak Nathiya, Beneen Husseen, Mansour Rajabivahid, Mahmoud Dehghani-Ghorbi, Reza Akhavan-Sigari
    Cell Biochemistry and Biophysics.2024; 83(1): 279.     CrossRef
  • 3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation
    Lubomir Skladany, Natalia Kubanek, Svetlana Adamcova Selcanova, Daniela Zilincanova, Daniel Havaj, Karolina Sulejova, Katarina Soltys, Lucia Messingerova, Michal Lichvar, Lukas Laffers, Michal Zilincan, Eva Honsova, Peter Liptak, Peter Banovcin, Jan Bures
    EPMA Journal.2024; 15(4): 677.     CrossRef
  • Protective effects of sulfated polysaccharides from Enteromorpha intestinalis on oxidative stress, liver iron overload and Ferroptosis in Zebra fish exposed to ethanol
    Marziyeh Khazaei, Rashid Alijani Ardeshir
    Biomedicine & Pharmacotherapy.2024; 181: 117715.     CrossRef
  • Effect of aerobic exercise on GRP78 and ATF6 expressions in mice with non-alcoholic fatty liver disease
    Junhan Li, Lei Huang, Wei Xiong, Chun Gu, Shuling Zhang, Xiali Xue
    Sports Medicine and Health Science.2023; 5(2): 112.     CrossRef
  • Luteolin ameliorates palmitate-induced lipotoxicity in hepatocytes by mediating endoplasmic reticulum stress and autophagy
    Chun-Yin Huang, Haw-Wen Chen, Chia-Wen Lo, Yu-Ru Wang, Chien-Chun Li, Kai-Li Liu, Chong-Kuei Lii
    Food and Chemical Toxicology.2023; 171: 113554.     CrossRef
  • Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
    Alessandra Scagliola, Annarita Miluzio, Stefano Biffo
    International Journal of Molecular Sciences.2023; 24(5): 4885.     CrossRef
  • Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
    Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques-Monteiro, Cristian Sandoval, Daiana Araujo Santana-Oliveira, Flavia Maria Silva-Veiga, Aline Fernandes-da-Silva, Vanessa Souza-Mello
    World Journal of Gastroenterology.2023; 29(26): 4136.     CrossRef
  • Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells
    Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
    Hiral Aghara, Prashsti Chadha, Devangi Zala, Palash Mandal
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Current Advances in the Regulatory Effects of Bioactive Compounds from Dietary Resources on Nonalcoholic Fatty Liver Disease: Role of Autophagy
    Yue Zhang, Qing Chen, Xiong Fu, Siming Zhu, Qiang Huang, Chao Li
    Journal of Agricultural and Food Chemistry.2023; 71(46): 17554.     CrossRef
  • Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease
    Sana Raza, Sangam Rajak, Rajani Singh, Jin Zhou, Rohit A Sinha, Amit Goel
    World Journal of Hepatology.2023; 15(12): 1272.     CrossRef
  • Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
    Julie Massart, Karima Begriche, Anne Corlu, Bernard Fromenty
    International Journal of Molecular Sciences.2022; 23(3): 1062.     CrossRef
  • The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis
    Li-Shuang Hou, Yao-Wen Zhang, Hua Li, Wei Wang, Meng-Lei Huan, Si-Yuan Zhou, Bang-Le Zhang
    Pharmacology & Therapeutics.2022; 234: 108117.     CrossRef
  • ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets
    Caroline C. Duwaerts, Jessica L. Maiers
    Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
  • Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria
    Yingying Shi, Zhenyu Luo, Jian You
    WIREs Nanomedicine and Nanobiotechnology.2022;[Epub]     CrossRef
  • Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet
    Nadiah S. Alzahrani, Ghedeir M. Alshammari, Afaf El-Ansary, Abu ElGasim A. Yagoub, Musarat Amina, Ali Saleh, Mohammed Abdo Yahya
    Nutrients.2022; 14(9): 1791.     CrossRef
  • Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study
    Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak
    Hepatology.2022; 76(6): 1746.     CrossRef
  • Identifying Autophagy-Related lncRNAs and Potential ceRNA Networks in NAFLD
    Ziyi Cao, Li Guan, RunZhi Yu, Jie Chen
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Protective effect of fucoidan against iron overload and ferroptosis-induced liver injury in rats exposed to alcohol
    Meilan Xue, Yingjie Tian, Yingzhong Sui, Hui Zhao, Haiqi Gao, Hui Liang, Xia Qiu, Zhanyi Sun, Yi Zhang, Yimin Qin
    Biomedicine & Pharmacotherapy.2022; 153: 113402.     CrossRef
  • The protective effect of puerarin-loaded mesoporous silicon nanoparticles on alcoholic hepatitis through mTOR-mediated autophagy pathway
    Xia-xia Zhang, Yan-fei Lang, Xin Li, Zheng Li, You-qing Xu, Hong-qian Chu
    Biomedical Microdevices.2022;[Epub]     CrossRef
  • Suppression of endoplasmic reticulum stress-associated pathways and hepatocyte apoptosis participates in the attenuation of betulinic acid on alcohol-provoked liver injury in mice
    Enqi He, Yurong Ma, Li Kong, You Huang, Chunlin Huang, Wenjiang Yang, Jine Yi, Lijuan Zhu
    Food & Function.2022; 13(22): 11489.     CrossRef
  • Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
    Qian-Long Wu, Shu-Xin Zeng, Jia-Ying Peng, Yi Yuan, Zhi Zhu, Zi-Chun Xie, Ze-Hong Huang, Jia-Shuan Huang, Jian-Mei Lai, Jin-an Chen, Min-Hua Lin
    Expert Review of Gastroenterology & Hepatology.2022; 16(9): 863.     CrossRef
  • Netrin-1 attenuates hepatic steatosis via UNC5b/PPARγ-mediated suppression of inflammation and ER stress
    Sung Woo Choi, Heeseung Oh, Seung Yeon Park, Wonjun Cho, A.M. Abd El-Aty, Nurcan Kilic Baygutalp, Ji Hoon Jeong, Tae Woo Jung
    Life Sciences.2022; 311: 121149.     CrossRef
  • Non-alcoholic fatty liver disease and liver secretome
    Muhammad Sohaib Khan, Choongho Lee, Sang Geon Kim
    Archives of Pharmacal Research.2022; 45(12): 938.     CrossRef
  • Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
    Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo
    Clinical and Molecular Hepatology.2021; 27(3): 463.     CrossRef
  • Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
    Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro
    Translational Oncology.2021; 14(9): 101158.     CrossRef
  • Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives
    Christina-Maria Flessa, Ioannis Kyrou, Narjes Nasiri-Ansari, Gregory Kaltsas, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
    Current Obesity Reports.2021; 10(2): 134.     CrossRef
  • 16,722 View
  • 300 Download
  • 50 Web of Science
  • Crossref